From: Novel strategies for immuno-oncology breakthroughs with cell therapy
Presenter | Target | Co-stimulatory molecule | Tumor type | Registration Number |
---|---|---|---|---|
Prasad Adusumilli | Mesothelin | CD28 | Mesothelioma TNBC | NCT02414269 |
Mesothelin | CD28 with PD-1 dominant negative receptor | Mesothelioma | NCT04577326 | |
Marcela Maus | EGFRvIII | 4-1BB | Glioblastoma | NCT02209376 |
Stanley Riddell | ROR1 | 4-1BB | ROR1 positive: Lung cancer TNBC Hematologic malignancies | NCT02706392 |